Arrowhead制药
35.41
-0.65
-1.80%
ARWR
10-10 16:00:00(美东时间)
高
36.10
开
36.00
量
182.96万股
总市值
48.96亿
低
34.91
换
1.32%
额
6491.02万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
Arrowhead制药(ARWR)
10-11 04:05
$Arrowhead制药(ARWR)$
10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000879407-25-000013 Act: 34 Size: 1 MB
网页链接
Arrowhead制药(ARWR)
10-04 06:25
$Arrowhead制药(ARWR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001830755-25-000011 Size: 5 KB
网页链接
Arrowhead制药(ARWR)
10-02 03:55
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0001628280-25-043402 Act: 33 Size: 9 KB
网页链接
1赞
Arrowhead制药(ARWR)
09-17 06:15
$Arrowhead制药(ARWR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001830755-25-000009 Size: 5 KB
网页链接
Arrowhead制药(ARWR)
09-13 04:35
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0002007317-25-001083 Act: 33 Size: 9 KB
网页链接
Arrowhead制药(ARWR)
09-13 04:05
$Arrowhead制药(ARWR)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0000879407-25-000010 Act: 34 Size: 46 MB
网页链接
Arrowhead制药(ARWR)
09-11 19:35
$Arrowhead制药(ARWR)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0000879407-25-000007 Act: 34 Size: 53 MB
网页链接
Arrowhead制药(ARWR)
09-05 05:45
$Arrowhead制药(ARWR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001830755-25-000007 Size: 5 KB
网页链接
Arrowhead制药(ARWR)
09-03 05:15
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0002007317-25-001016 Act: 33 Size: 8 KB
网页链接
Arrowhead制药(ARWR)
09-03 04:05
$Arrowhead制药(ARWR)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0000879407-25-000004 Act: 34 Size: 242 KB
网页链接
Arrowhead制药(ARWR)
08-16 06:05
$Arrowhead制药(ARWR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001830755-25-000005 Size: 6 KB
网页链接
Arrowhead制药(ARWR)
08-16 05:35
$Arrowhead制药(ARWR)$
SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950170-25-109461 Act: 34 Size: 185 KB
网页链接
Arrowhead制药(ARWR)
08-16 03:45
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0002007317-25-000884 Act: 33 Size: 7 KB
网页链接
Arrowhead制药(ARWR)
08-14 19:15
$Arrowhead制药(ARWR)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003580 Act: 34 Size: 11 KB
网页链接
Arrowhead制药(ARWR)
08-14 09:05
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0000950170-25-108325 Act: 33 Size: 5 KB
网页链接
Arrowhead制药(ARWR)
08-14 06:05
$Arrowhead制药(ARWR)$
144 Report of proposed sale of securities Accession Number: 0002007317-25-000866 Act: 33 Size: 7 KB
网页链接
Arrowhead制药(ARWR)
08-13 05:55
$Arrowhead制药(ARWR)$
3 Initial statement of beneficial ownership of securities Accession Number: 0002081169-25-000003 Size: 4 KB
网页链接
Arrowhead制药(ARWR)
08-11 19:05
$Arrowhead制药(ARWR)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000093751-25-000436 Act: 34 Size: 8 KB
网页链接
Arrowhead制药(ARWR)
08-08 04:15
$Arrowhead制药(ARWR)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-038858 Act: 34 Size: 9 MB
网页链接
1转发
·
1讨论
Arrowhead制药(ARWR)
08-08 04:15
$Arrowhead制药(ARWR)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-25-038867 Act: 34 Size: 296 KB
网页链接